Policy Changes Needed to Address Biomarker Testing Disparities for Medicaid Patients, Experts Say

Lung cancer patients on Medicaid face many hurdles in accessing care, not least of which is difficulty getting covered access to evidence-based biomarker testing.

Related Keywords

United States ,Rhode Island ,Louisiana ,Arizona ,California ,Illinois ,Ohio ,American ,Ken Kehl ,Gee Goeckner ,Hilary Gee Goeckner ,Centers For Medicare Medicaid Services ,Genentech ,American Society Of Clinical Oncology ,Journal Of The National Comprehensive Cancer Network ,Flatiron Health ,American Cancer Society Action Network ,Dana Farber Cancer Institute ,National Comprehensive Cancer Network ,Medicaid Services ,American Society ,